Table of Contents Table of Contents
Previous Page  477 / 812 Next Page
Information
Show Menu
Previous Page 477 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

S473

Table 2

Anova de un factor.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1375

EV391

ADHD “Symptomatic contamination”

in dual pathology (II): Specific analysis

of the “Sym Con” sample

F.J. Pino Calderon

1 ,

, J.M. Zoido Ramos

2

, J.R. Gutierrez Casares

3

1

Servicio Extreme˜no de Salud, ESM Montijo-Puebla, Montijo, Spain

2

Servicio Extreme˜no de Salud, CEDEX “Los Pinos”, Badajoz, Spain

3

Servicio Extreme˜no de Salud, Hospital Perpetuo Socorro, Psichiatría,

Badajoz, Spain

Corresponding author.

Introduction

The general data of this sample were presented in

“ADHD symptomatic contamination in a Dual Pathology (I): Gen-

eral Analysis of the Sym Con Sample”. We evaluated the presence

of symptomatic contamination by ADHD in a SUD group compared

with a group of non-consumers adults (parents of children treated

in a CAP unit).

Objective and aims

Describe more specifically the peculiarities of

the sample Sym Con according to the type of substance consump-

tion (Alcohol [

n

= 65], Cocaine [

n

= 48], Cannabis [

n

= 49] assessing

the presence of ADHD symptomatic contamination.

Methods

We use differents Visual Analogical Scales plus the

WURS, BDI, and Exploratory Lists of symptoms of ADHD.

Results

As can be seen in

Tables 1 and 2 ,

the subgroup of Alco-

hol has a poorer “scalar” status with worse general state, more

sadness and anxiety, being the subgroup of cocaine themost “suspi-

cious”. The presence of ADHD-symptomatic contamination is more

noticeable in the Cannabis subgroup.

Conclusions

ADHD symptomatic contamination in our Sym Con

sample is frequent, being the cannabis subgroup the more

contaminated one. More studies that corroborate the results

obtained in this sample are required.

Table 1

Informe.

Table 2

Anova de un factor.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1376

EV392

Comorbidity between delusional

disorder and depression. Results from

the DelirAnda case register

A. Porras Segovia

1 ,

, C. Carrillo de Albornoz Calahorro

2

,

M. Guerrero Jiménez

2

, J. Cervilla Ballesteros

1 , 3

1

University hospital San Cecilio, mental health services, Granada,

Spain

2

Santa Ana hospital, mental health services, Motril, Spain

3

University of Granada, psychiatry department, Granada, Spain

Corresponding author.

Introduction

Comorbidity between two ormoremental disorders

is highly frequent. Depression is one of the diseases that more often

accompanies other conditions.

Objectives

The objective of this study is to establish the preva-

lence of depression in patients with delusional disorder and

describe the treatment used in these cases.

Aims

The aim is to provide useful information regarding this fre-

quent, often disregarded, comorbidity.

Methods

Our results proceed from the Andalusian delusional dis-

order case register. We reviewed 1927 clinical histories of patients

diagnosed of delusional disorder. Upon having verified the diagno-

sis, following DSM-V criteria, we recollected several data, including